Brochet, B., Hupperts, R., Langdon, D., Solari, A., Piehl, F., Lechner-Scott, J., . . . Keller, B. (2022). Treatment satisfaction, safety, and tolerability of cladribine tablets in patients with highly active relapsing multiple sclerosis.
Citación estilo ChicagoBrochet, Bruno, et al. Treatment Satisfaction, Safety, and Tolerability of Cladribine Tablets in Patients With Highly Active Relapsing Multiple Sclerosis. 2022.
Cita MLABrochet, Bruno, et al. Treatment Satisfaction, Safety, and Tolerability of Cladribine Tablets in Patients With Highly Active Relapsing Multiple Sclerosis. 2022.
Precaución: Estas citas no son 100% exactas.